Review Article
Volume 9 Issue 4 - 2020
Spinal Muscular Atrophy in Samara Region. Epidemiology, Classification, Prospects for Health Care
Arseny I Gayduk* and Vlasov YaV
Neurology and Neurosurgery Department, Samara State Medical University, Samara, Russian Federation
*Corresponding Author: Arseny I Gayduk, Neurology and Neurosurgery Department, Samara State Medical University, Samara, Russian Federation.
Received: February 28, 2020; Published: March 23, 2020




Abstract

In this article we discuss in detail the issue of spinal muscular atrophy in Russia and particularly in the Samara Regional Clinical Hospital n.a. V.D. Seredavin (Samara region) where a total of 58 living patients with SMA were registered by June 2019, 19 of them were children. The issues of classification and etiopathogenesis, prospects of pathogenetic treatment and prevention of SMA are being discussed.

Keywords: Hereditary Neuromuscular Diseases; Pathogenetic Treatment; Spinal Muscular Atrophy; Sma; Samara Region; Genetic Testing; Risdiplam; Nusinersen; Avxs-101

References

  1. Zabnenkova VV., et al. “Proximal spinal muscular atrophy of types I-IV: peculiarities of molecular genetic diagnostics”. Neuromuscular Diseases 3 (2013) : 27-31.
  2. Dadali EL., et al. “Clinical and genetic characteristics of spinal muscular atrophy with predominant leg lesions caused by mutations in the DYNC1H1 gene”. Neuromuscular Diseases 8.2 (2018): 59-67. 
  3. Cathy Lally., et al. “Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States”. Orphanet Journal of Rare Diseases 12.1 (2017): 175.
  4. Adele D'Amico., et al. “Spinal muscular atrophy”. Orphanet Journal of Rare Diseases 6 (2011): 71.
  5. Singh RN., et al. “Diverse role of survival motor neuron protein”. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms 1860.3 (2017): 299-315.
  6. Brzustowicz LM., et al. "Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11. 2-13. 3". Nature 344 (6266): 540-541.
  7. Jedrzejowska M., et al. "Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease". Acta Biochimica Polonica 56.1 (2009): 103-108. 
  8. Lefebvre S., et al. "Identification and characterization of a spinal muscular atrophy-determining gene". Cell 80.1 (1995): 155-165. 
  9. Singh NN., et al. "A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy". RNA Biology 6 .3 (2009): 341-350. 
  10. Giavazzi A., et al. "Neuronal-specific roles of the survival motor neuron protein: evidence from survival motor neuron expression patterns in the developing human central nervous system". Journal of Neuropathology and Experimental Neurology 65.3 (2006): 267-277. 
  11. Iwahashi H., et al. "Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy". Nature 390.6658 (1997): 413-417. 
  12. Hebert MD., et al. "Coilin methylation regulates nuclear body formation". Developmental Cell 3.3 (2002): 329-337. 
  13. Carnegie GK., et al. "Protein phosphatase 4 interacts with the Survival of Motor Neurons complex and enhances the temporal localisation of snRNPs". Journal of Cell Science 116.10 (2003): 1905-1913. 
  14. Meister G., et al. "Characterization of a nuclear 20S complex containing the survival of motor neurons (SMN) protein and a specific subset of spliceosomal Sm proteins". Human Molecular Genetics 9.13 (2000): 1977-1986.
  15. Pellizzoni L., et al. "A functional interaction between the survival motor neuron complex and RNA polymerase II". The Journal of Cell Biology 152.1 (2001): 75-85. 
  16. Pellizzoni L., et al. "The survival of motor neurons (SMN) protein interacts with the snoRNP proteins fibrillarin and GAR1". Current Biology 11.14 (2001): 1079-1088.
  17. Williams BY., et al. "The survival motor neuron protein interacts with the transactivator FUSE binding protein from human fetal brain". FEBS Letters 470.2 (2000): 207-210. 
  18. Gubitz AK., et al. "Gemin5, a novel WD repeat protein component of the SMN complex that binds Sm proteins". The Journal of Biological Chemistry 277.7 (2002): 5631-5636. 
  19. Baccon J., et al. "Identification and characterization of Gemin7, a novel component of the survival of motor neuron complex". The Journal of Biological Chemistry 277.35 (2002): 31957-31962. 
  20. Mourelatos Z., et al. "SMN interacts with a novel family of hnRNP and spliceosomal proteins". The EMBO Journal 20.19 (2001): 5443-5452. 
  21. Narayanan U., et al. "SMN, the spinal muscular atrophy protein, forms a pre-import snRNP complex with snurportin1 and importin beta". Human Molecular Genetics 11.15 (2002): 1785-1795. 
  22. Young PJ., et al. "A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy". The Journal of Biological Chemistry 277.4 (2002): 2852-2859. 
  23. Oskoui M., et al. "Chapter 1". In Sumner CJ, Paushkin S, Ko CP (eds. ). Spinal Muscular Atrophy: Disease Mechanisms, Elsevier (2017).
  24. Wang CH., et al. “Consensus statement for standard of care in spinal muscular atrophy”. Journal of Child Neurology 22.8 (2007): 1027-1049.
  25. Finkle RS., et al. “218th ENMC International Workshop:Revisiting the consensus on standards of care in SMA Naarden, The Netherlands, 19-21 February 2016”. Neuromuscular Disorders 27 (2017): 596-605. 
  26. Vlodavets DV., et al. “Federal clinical recommendations (protocols) on diagnosis and treatment of spinal muscular atrophy in children” (2013). 
  27. Recommendations for patient management and respiratory support in spinal muscular atrophy (SMA) types 1-3. First Conciliation Meeting of the Association “SMA Families” (Italy), Rome, Italy, (2015).
  28. Spiegler AWJ., et al. “Population data on acute infantile and chronic childhood spinal muscular atrophy in Warsaw”. Human Genetics 85 (1990): 211-214. 
  29. Zaldivar T., et al. “Evidence of reduced frequency of spinal muscular atrophy type I in the Cuban population”. Neurology 65 (2005): 636-638. 
  30. Mostacciuolo ML., et al. “Epidemiology of spinal muscular atrophies in a sample of the Italian population”. Neuroepidemiology 11 (1992): 34-38. 
  31. Wilmshurst JM., et al. “Spinal muscular atrophy in black South Africans: concordance with the universal SMN1 genotype”. Clinical Genetics 62 (2002): 165-168. 
  32. Hendrickson BC., et al. “Differences in SMN1 allele frequencies among ethnic groups within North America”. Journal of Medical Genetics 46 (2009): 641-644. 
  33. Lazarin GA., et al. “An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals”. Genetics in Medicine 15 (2013): 178-186. 
  34. Garber K. "Big win possible for Ionis/Biogen antisense drug in muscular atrophy". Nature Biotechnology 34.10 (2016): 1002-1003. 
  35. Article on AVXS-101 on Novartis website.
  36. Sugarman EA., et al. “Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of > 72,400 specimens”. European Journal of Human Genetics : EJHG 20.1 (2012): 27-32. 
  37. Akhmedova Patimat Huseynovna. “Epidemiology of hereditary neuromuscular diseases in the Republic of Dagestan”. Development of the basics of the neuroregister: Graduation paper of the Candidate of Medical Sciences (2015): 35.
  38. Valeria Parente and Stefania Corti. “Advances in spinal muscular atrophy therapeutics”. Therapeutic Advances in Neurological Disorders. 
  39. Surosky RT., et al. "Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome". Journal of Virology 71.10 (1997).
  40. Presentation of the results of clinical trials of Risdiplam by Roche (2019). 
  41. Pinard Emmanuel., et al. “Discovery of a Novel Class of Survival Motor Neuron 2 Splicing Modifiers for the Treatment of Spinal Muscular Atrophy”. Journal of Medicinal Chemistry 60.10 (2017): 4444-4457.
Citation: Arseny I Gayduk and Vlasov YaV. “Spinal Muscular Atrophy in Samara Region. Epidemiology, Classification, Prospects for Health Care”. EC Psychology and Psychiatry 9.4 (2020): 35-42.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for September Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the September issue of respective journals. Submissions are accepted on/before August 15, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk